Braveheart Bio, Inc. (BRVE) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$1.89B

MomentumView details →

1D Return

+1.79%

YTD Return

—

RSI (14)

62.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$1.89B

RSI (14)

62.7

MomentumView details →

1D Return

+1.79%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

$0.85

EPS Surprise

−68.40%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

−68.40%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsDec 2, 2026 →

Latest newsMore news →

No recent news for BRVE.

Similar companies

*ST海利603718.SH Galapagos N.V. Sponsored ADRLKFT Immunocore Holdings plcIMCR Damora Therapeutics, Inc.DMRA Stoke Therapeutics, Inc.STOK Vir Biotechnology, Inc.VIR Find similar companies →

Latest newsMore news →

No recent news for BRVE.